These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50 related articles for article (PubMed ID: 9363096)
1. Current concepts in and modes for measurement of activity in interstitial lung disease. Winterbauer RH Curr Opin Pulm Med; 1995 Sep; 1(5):358-62. PubMed ID: 9363096 [TBL] [Abstract][Full Text] [Related]
4. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression. Goh NS; Veeraraghavan S; Desai SR; Cramer D; Hansell DM; Denton CP; Black CM; du Bois RM; Wells AU Arthritis Rheum; 2007 Jun; 56(6):2005-12. PubMed ID: 17530640 [TBL] [Abstract][Full Text] [Related]
5. Chitotriosidase activity in patients with interstitial lung diseases. Bargagli E; Margollicci M; Luddi A; Nikiforakis N; Perari MG; Grosso S; Perrone A; Rottoli P Respir Med; 2007 Oct; 101(10):2176-81. PubMed ID: 17631992 [TBL] [Abstract][Full Text] [Related]
6. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Jegal Y; Kim DS; Shim TS; Lim CM; Do Lee S; Koh Y; Kim WS; Kim WD; Lee JS; Travis WD; Kitaichi M; Colby TV Am J Respir Crit Care Med; 2005 Mar; 171(6):639-44. PubMed ID: 15640368 [TBL] [Abstract][Full Text] [Related]
7. Resting and exercise physiology in interstitial lung diseases. Lama VN; Martinez FJ Clin Chest Med; 2004 Sep; 25(3):435-53, v. PubMed ID: 15331185 [TBL] [Abstract][Full Text] [Related]
8. Clinical advances in the diagnosis and therapy of the interstitial lung diseases. King TE Am J Respir Crit Care Med; 2005 Aug; 172(3):268-79. PubMed ID: 15879420 [TBL] [Abstract][Full Text] [Related]
9. [Extracellular components of broncho-alveolar lavage fluid (BALF) as markers of interstitial pulmonary disease activity. II. Phospholipid concentration]. Zielonka TM; Wałajtys-Rode E; Jasińska R; Chazan R; Droszcz W Przegl Lek; 1998; 55(12):654-8. PubMed ID: 10354716 [TBL] [Abstract][Full Text] [Related]
10. [Efficacy of ab initio immunosuppressive therapy and steroid-sparing effect in interstitial lung disease associated with antisynthetase antibody syndrome]. Franzolini N; Quartuccio L; De Marchi G; De Vita S Reumatismo; 2007; 59(3):202-8. PubMed ID: 17898879 [TBL] [Abstract][Full Text] [Related]
11. Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease. Mittoo S; Wigley FM; Wise R; Xiao H; Hummers L Arthritis Rheum; 2007 Dec; 56(12):4195-202. PubMed ID: 18050251 [TBL] [Abstract][Full Text] [Related]
12. [Extracellular components of bronchoalveolar lavage fluid (BALF) as a marker of the activity of interstitial pulmonary diseases. III: Phospholipids to protein concentration ratio]. Zielonka TM; Wałajtys-Rode E; Jasińska R; Chazan R; Droszcz W Przegl Lek; 1999; 56(2):144-7. PubMed ID: 10375948 [TBL] [Abstract][Full Text] [Related]
14. Lung disease in Niemann-Pick disease. Guillemot N; Troadec C; de Villemeur TB; Clément A; Fauroux B Pediatr Pulmonol; 2007 Dec; 42(12):1207-14. PubMed ID: 17969000 [TBL] [Abstract][Full Text] [Related]
15. Bronchoalveolar lavage in interstitial lung diseases: does the recovery rate affect the results? Schildge J; Nagel C; Grun C Respiration; 2007; 74(5):553-7. PubMed ID: 17496412 [TBL] [Abstract][Full Text] [Related]
16. [Role of endothelial dysfunction and coagulation disorders in the development of pulmonary fibrosis in patients with interstitial lung diseases]. Ppova EN; Arkhipova DV; Kozlovskaia LV; Privalova EV; Bitsadze VO; Kornev BM Klin Med (Mosk); 2004; 82(6):38-42. PubMed ID: 15344689 [TBL] [Abstract][Full Text] [Related]